cholic acid has been researched along with Autoimmune Diabetes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, X; Qian, K; Yao, P | 1 |
| Al-Salami, H; Calasan, J; Golocorbin-Kon, S; Lalic-Popovic, M; Mikov, M; Milijasevic, B; Vukmirovic, S | 1 |
| Al-Salami, H; Chen-Tan, N; Golocorbin-Kon, S; Lalic-Popovic, M; Martinez, J; Mathavan, S; Mikov, M; Mooranian, A; Mukkur, TK; Negrulj, R; Sciarretta, J; Stojancevic, M | 1 |
3 other study(ies) available for cholic acid and Autoimmune Diabetes
| Article | Year |
|---|---|
Insulin- and cholic acid-loaded zein/casein-dextran nanoparticles enhance the oral absorption and hypoglycemic effect of insulin.
Topics: Administration, Oral; Alloxan; Animals; Biological Availability; Caseins; Cholic Acid; Dextrans; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Hypoglycemic Agents; Insulin; Male; Materials Testing; Mice; Mice, Inbred ICR; Nanoparticles; Optical Imaging; Zein | 2021 |
High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect.
Topics: Animals; Bile Acids and Salts; Blood Glucose; Cholic Acid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Compounding; Drug Interactions; Gliclazide; Hypoglycemic Agents; Male; Rats | 2017 |
An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations.
Topics: Administration, Oral; Alginates; Animals; Capsules; Cholic Acid; Diabetes Mellitus, Type 1; Drug Carriers; Drug Compounding; Excipients; Gliclazide; Glucuronic Acid; Hexuronic Acids; Hypoglycemic Agents; Rats | 2015 |